Tekla Healthcare Investors Share Price Nyse
Equities
US4040521027
Closed End Funds
End-of-day quote
Other stock markets
|
||
- USD | - |
|
Sales 2022 | 8.27M 690M | Sales 2023 | 10.29M 859M | Capitalization | 752M 62.74B |
---|---|---|---|---|---|
Net income 2022 | -194M -16.19B | Net income 2023 | 56M 4.67B | EV / Sales 2022 | 97.9 x |
Net Debt 2022 | 8.49M 709M | Net cash position 2023 | 214 17.86K | EV / Sales 2023 | 73.1 x |
P/E ratio 2022 |
-4.21
x | P/E ratio 2023 |
13.6
x | Employees | - |
Yield 2022 |
10.6% | Yield 2023 |
10.4% | Free-Float | 95.5% |
Managers | Title | Age | Since |
---|---|---|---|
Dan Omstead
PSD | President | 71 | 01/01/01 |
Chief Tech/Sci/R&D Officer | - | - | |
Jason Akus
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 74 | 01/07/01 | |
Dan Omstead
PSD | President | 71 | 01/01/01 |
Jeffrey Bailey
BRD | Director/Board Member | 62 | 01/20/01 |
1st Jan change | Capi. | |
---|---|---|
+4.64% | 12.88B | |
+14.01% | 9.75B | |
+0.90% | 5.64B | |
+6.18% | 5.22B | |
+28.22% | 5.08B | |
-9.20% | 4.82B | |
+21.32% | 4.64B | |
-1.53% | 3.86B | |
+2.09% | 3.86B |